
Genvax Technologies Inc
UnclaimedBiological Product (except Diagnostic) ManufacturingAmes, IA
Founded
2021
Primary NAICS
325414
CAGE code
8ZRY0
Federal awards
—
Overview
Genvax Technologies develops next-generation mRNA + nanoparticle vaccines for livestock — delivering faster, more effective vaccines that protect animal health and strengthen the global food supply.
Classification
This U.S. industry comprises establishments primarily engaged in manufacturing vaccines, toxoids, blood fractions, and culture media of plant or animal origin (except diagnostic).
- Manufacturing32
- Chemical Manufacturing325
- Pharmaceutical and Medicine Manufacturing32541
- Biological Product (except Diagnostic) Manufacturing325414